Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses

• Xuenian Chen,
• Tongfei Shi,
• Chao Yang,
• Fangman Chen,
• Xuan He,
• Kunbao Zhang,
• Hanze Hu,
• Lulu Cai,
• Kam W. Leong,
• Dan Shao

Affiliations

Xuenian Chen

School of Biomedical Sciences and Engineering, South China University of Technology

Tongfei Shi

School of Biomedical Sciences and Engineering, South China University of Technology

Chao Yang

School of Biomedical Sciences and Engineering, South China University of Technology

Fangman Chen

School of Biomedical Sciences and Engineering, South China University of Technology

Xuan He

School of Biomedical Sciences and Engineering, South China University of Technology

Kunbao Zhang

School of Biomedical Sciences and Engineering, South China University of Technology

Hanze Hu

Department of Biomedical Engineering, Columbia University

Lulu Cai

Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China

Kam W. Leong

Department of Biomedical Engineering, Columbia University

Dan Shao

School of Biomedical Sciences and Engineering, South China University of Technology